(Updated - June 26, 2026 8:15 AM EDT)

Canaccord analyst Edward Nash raised the price target on Kymera Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE